Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lab4b
- Development stage
- Unknown
- Lead developer
- Cultech
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lab4b is a proprietary multi-strain probiotic consortium developed by Cultech, consisting of four specific strains of lactic acid bacteria: Lactobacillus acidophilus (CUL60 and CUL21), Bifidobacterium bifidum (CUL20), and Bifidobacterium animalis subsp. lactis (CUL34). It is specifically formulated for use in pregnancy and early infancy to support the development of a healthy gut microbiome and immune system. In clinical research, such as the PROSYNK trial, Lab4b has been evaluated for its ability to reduce chronic systemic inflammation (CSI) and improve biomarkers of environmental enteric dysfunction (EED) in infants living in high-risk environments. The formulation is available as a standalone probiotic or as a synbiotic when combined with prebiotic fructooligosaccharides (FOS).
- Brand names
- ProVen Probiotics Lab4b
- Other names
- Lab4b probioticLab-4b probioticLab 4b probioticLab4b synbioticLab-4b synbioticLab 4b synbiotic
Beyond the preview
Go deeper on Lab4b.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lab4b.